FTC sues major pharmacy benefit administrators over insulin prices The agency brought motion in opposition to Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list price of lifetime-saving insulin medication. Sanders quickly condemned the move in a statement Wednesday, noting he was https://zanderzwsqn.tkzblog.com/30527892/rumored-buzz-on-healthcare-news